Delivery Order SPE2DB20D3111-SPE2DB25FA8WA
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,071.25 for Lantus SoloStar 100 Unit/mL 3mL insulin pens on August 19, 2025, with completion scheduled for August 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a routine pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the...
- The Defense Logistics Agency awarded a $2,348.65 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens, with an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,033.47 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. The contract was competitively awarded without set-aside designation under a firm fixed-price arrangement, with performance scheduled for completion by August 18, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a $5,369.70 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML insulin pens on September 15, 2025, with completion expected by September 16, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The contract reflects AmerisourceBergen's role as a critical federal vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,673.20 to supply Lantus SoloStar 100 Unit/mL 3mL insulin pens, with a completion date of September 16, 2025. This non-set-aside, competitively awarded contract employs firm fixed price terms and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $4,038.26 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens on June 13, 2025, with an ultimate completion date of June 16, 2025. This firm fixed-price, competitively awarded contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,172.50 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin pens on September 9, 2025, with completion targeted for September 10, 2025. This competitive, non-set-aside award utilizes firm fixed pricing and represents a direct fulfillment of pharmaceutical supply needs for the Department of Defense. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,534.20 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens on June 26, 2025, with completion scheduled for June 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement needs. The order will be fulfilled at the company's...
- AmerisourceBergen Drug Corp was awarded a $1,197.07 firm fixed-price delivery order by the Defense Logistics Agency on July 18, 2025, for Lantus SoloStar 100 Unit/ML 3ML insulin pens. This is a non-set-aside competitive award with an ultimate completion date of July 21, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $1,022.80 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin pens. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on May 30, 2025, with an ultimate completion date of June 2, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA8WADelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,770.53 for Lantus SoloStar 100 Unit/mL 3mL insulin pens on August 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 12, 2025. The products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. This comprehensive pharmaceutical prime vendor contract enables the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen's federal contract portfolio demonstrates its role as a critical pharmaceutical distributor for DoD and other government healthcare systems, with consistent awards covering specialty medications, brand-name and generic drugs, and specialized medical supplies across multiple therapeutic areas.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/11/25 |